These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2838641)

  • 21. Receptors for human plasminogen on the biological response modifier OK-432.
    Ullberg M; Tewodros W; Kronvall G
    J Biol Response Mod; 1990 Dec; 9(6):592-6. PubMed ID: 1963635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annexin A2 may not play a role as a plasminogen receptor.
    Waisman DM
    Br J Haematol; 2005 Nov; 131(4):553-4; author reply 554-6. PubMed ID: 16281949
    [No Abstract]   [Full Text] [Related]  

  • 23. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.
    Godár S; Horejsi V; Weidle UH; Binder BR; Hansmann C; Stockinger H
    Eur J Immunol; 1999 Mar; 29(3):1004-13. PubMed ID: 10092105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
    Swiercz R; Wolfe JD; Zaher A; Jankun J
    Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer. Proteases--invasion and more.
    Edwards DR; Murphy G
    Nature; 1998 Aug; 394(6693):527-8. PubMed ID: 9707109
    [No Abstract]   [Full Text] [Related]  

  • 27. Receptor for plasmin on human carcinoma cells.
    Burtin P; Fondaneche MC
    J Natl Cancer Inst; 1988 Jul; 80(10):762-5. PubMed ID: 2838642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
    Al-Atrash G; Kitson RP; Xue Y; Mazar AP; Kim MH; Goldfarb RH
    Anticancer Res; 2001; 21(3B):1697-704. PubMed ID: 11497249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of the streptokinase gene prevents Streptococcus equisimilis H46A from acquiring cell-associated plasmin activity in the presence of plasminogen.
    Malke H; Mechold U; Gase K; Gerlach D
    FEMS Microbiol Lett; 1994 Feb; 116(1):107-12. PubMed ID: 8132150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis.
    Knaust A; Weber MV; Hammerschmidt S; Bergmann S; Frosch M; Kurzai O
    J Bacteriol; 2007 Apr; 189(8):3246-55. PubMed ID: 17307854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin.
    Ullberg M; Kuusela P; Kristiansen BE; Kronvall G
    J Infect Dis; 1992 Dec; 166(6):1329-34. PubMed ID: 1385549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of plasminogen/plasmin receptors on human glomerular epithelial cells.
    Becquemont L; Nguyen G; Peraldi MN; He CJ; Sraer JD; Rondeau E
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F303-10. PubMed ID: 7520669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical prospects for the study of the plasminogen activation system in breast cancer].
    Gershteĭn ES; Kushlinskiĭ NE
    Vestn Ross Akad Med Nauk; 1999; (8):58-61. PubMed ID: 10487126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells.
    Díaz VM; Hurtado M; Kort EJ; Resnati M; Blasi F; Thomson T; Paciucci R
    Exp Cell Res; 2006 Jul; 312(12):2203-13. PubMed ID: 16631161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of Trypanosoma evansi with the plasminogen-plasmin system.
    Acosta H; Rondón-Mercado R; Avilán L; Concepción JL
    Vet Parasitol; 2016 Aug; 226():189-97. PubMed ID: 27514905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells.
    Miles LA; Plow EF
    Thromb Haemost; 1987 Oct; 58(3):936-42. PubMed ID: 2829380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.